Literature DB >> 9682049

Acyclovir for recurrent herpes simplex virus ocular disease.

D A Jabs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9682049     DOI： 10.1056/NEJM199807303390510

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir.

Authors:  Jwala Jwala; Sai H S Boddu; Sujay Shah; Suman Sirimulla; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2011-04       Impact factor: 2.671

2.  Host-microbe interactions in cornea.

Authors:  Linda D Hazlett; Shunbin Xu; Mallika Somayajulu; Sharon A McClellan
Journal:  Ocul Surf       Date:  2021-10-04       Impact factor: 6.268

3.  Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.

Authors:  Soumyajit Majumdar; Tushar Hingorani; Ramesh Srirangam; Rama Sarma Gadepalli; John M Rimoldi; Michael A Repka
Journal:  Pharm Res       Date:  2008-10-07       Impact factor: 4.200

4.  Challenges of corneal infections.

Authors:  L Hazlett; Susmit Suvas; Sharon McClellan; Sandamali Ekanayaka
Journal:  Expert Rev Ophthalmol       Date:  2016-06-30

5.  Establishing a Herpesvirus Quiescent Infection in Differentiated Human Dorsal Root Ganglion Neuronal Cell Line Mediated by Micro-RNA Overexpression.

Authors:  Yu-Chih Chen; Hedong Li; Miguel Martin-Caraballo; Shaochung Victor Hsia
Journal:  Pathogens       Date:  2022-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.